Key facts
- It has raised $720K; the latest was Accelerator/Incubator in Nov 2025.
- Notable investors include Tech Incubator Program for Startup, Kakao Ventures, Digital Healthcare Partners, Kangwon National University Technology Holdings Company.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for FLONICS
- ·The full record, as it builds
Funding rounds
No funding rounds for FLONICS are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About FLONICS
Developer of medical imaging technologies intended for diagnostic and interventional applications. The Company integrates four-dimensional flow MRI capabilities, catheter simulation tools, and virtual modeling environments that support real-time visualization of blood flow dynamics, enabling clinical researchers and healthcare providers to improve procedural planning, enhance diagnostic accuracy, and explore non-invasive alternatives for vascular and cardiac assessments.
- Sector
- Healthcare
- HQ
- Chuncheon, South Korea
- Founded
- 2024
- Website
- flonics.co.kr/
- Ownership
- Privately Held (backing)
FLONICS doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in FLONICS shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on FLONICS in its N-PORT filings yet. We sweep new filings monthly.